The GEPIA database analysis results show that GNL3L is highly expressed in DLBC (diffuse large B-cell lymphoma), LAML (acute myeloid leukemia), LGG (low-grade glioma of the brain), and TGCT (testicular cancer) tumor tissues (Figure 1B). Here, GNL3L is linked to neoplasm.